九游体育

Journal News

Targeting Toxoplasma parasites and their protein accomplices

Oluwadamilola 鈥淒ami鈥 Oke
April 11, 2025

Toxoplasmosis is an infectious disease caused by the parasite Toxoplasma gondii and is transmitted via contaminated food or feces. The infection can cause a range of symptoms that may be mild or severe, resulting in blindness and brain infection. Current T. gondii therapeutics are not very effective, so scientists need to further investigate potential drug targets.

Sheena Dass and a team of researchers from the Universit茅 Grenoble Alpes, France, identified seven genes responsible for expressing enzymes of metabolic interest in these parasites. Their recent in the Journal of Lipid Research characterizes one of these enzymes, T. gondii acyl-CoA synthetase 3, or TgACS3.

TgACS3 was found to be localized in the cytosol of the parasite and to upregulate its parasitic growth while increasing its chances of survival within its host. Gas chromatography-mass spectrometry was implemented to analyze the lipid content in the parasite, which revealed the role of TgAC3 in the uptake and utilization of its host fatty acids, generating the parasite phospholipid layer, and maintaining the growth of new parasites.

This study is an important step towards achieving targeted therapeutic mechanisms in the treatment of Toxoplasmosis, as researchers can leverage the findings shared in a more rigorous analysis.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Oluwadamilola 鈥淒ami鈥 Oke

Oluwadamilola “Dami” Oke is a Ph.D. candidate of biomedical engineering at the George Washington University with an interest in communication and outreach for science advancement. She is an ASBMB Today contributing writer.

Related articles

Fat cells are a culprit in osteoporosis
Oluwadamilola 鈥淒ami鈥 Oke
From the Journals: JLR
Vanshika Patel
Meet Robert Helsley
Christopher Radka

Get the latest from ASBMB Today

Enter your email address, and we鈥檒l send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

New mass spectrometry tool accurately identifies bacteria
Journal News

New mass spectrometry tool accurately identifies bacteria

April 30, 2025

Scientists develop a software tool to categorize microbe species and antibiotic resistance markers to aid clinical and environmental research. Read about this recent article published in Molecular & Cellular Proteomics.

New tool matches microbial and metabolic metaproteomic data
Journal News

New tool matches microbial and metabolic metaproteomic data

April 30, 2025

Scientists develop a bioinformatics program that maps omics data to metabolic pathways. Read about this recent article published in Molecular & Cellular Proteomics

Meet Paul Shapiro
Interview

Meet Paul Shapiro

April 29, 2025

Learn how the JBC associate editor went from milking cows on a dairy farm to analyzing kinases in the lab.

CRISPR epigenome editor offers potential gene therapies
News

CRISPR epigenome editor offers potential gene therapies

April 25, 2025

Scientists from the University of California, Berkeley, created a system to modify the methylation patterns in neurons. They presented their findings at ASBMB 2025.

Finding a symphony among complex molecules
Profile

Finding a symphony among complex molecules

April 23, 2025

MOSAIC scholar Stanna Dorn uses total synthesis to recreate rare bacterial natural products with potential therapeutic applications.

E-cigarettes drive irreversible lung damage via free radicals
Journal News

E-cigarettes drive irreversible lung damage via free radicals

April 17, 2025

E-cigarettes are often thought to be safer because they lack many of the carcinogens found in tobacco cigarettes. However, scientists recently found that exposure to e-cigarette vapor can cause severe, irreversible lung damage.